Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Consensus | Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.62B | $44.29 | $60.33 | 36.22% | Buy | 6 | 28.47% | 58.10% | 120.95% | 59.04% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $10.16B | $106.21 | $113.00 | 6.39% | Buy | 13 | 15.09% | 250.25% | 49.99% | 35.48% | |
| GMAB | GENMAB A | $21.12B | $32.13 | $37.15 | 15.61% | Sell | 7 | 26.47% | 24.60% | 4.72% | 4.20% | |
| HALO | HALOZYME THERAPEUTICS INC | $5.45B | $39.54 | $52.00 | 31.51% | Strong Buy | 3 | 28.26% | 16.06% | 259.89% | 42.77% | |
| CPRX | CATALYST PHARMACEUTICALS INC | $1.32B | $12.83 | $16.83 | 31.20% | Buy | 3 | 15.02% | 20.76% | 41.79% | 37.70% | |
| EXEL | EXELIXIS INC | $5.05B | $15.68 | $30.43 | 94.06% | Buy | 7 | 11.92% | 23.67% | 27.32% | 22.67% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $101.42M | $7.50 | $15.00 | 100.00% | Strong Buy | 2 | 15.85% | 287.30% | 67.74% | 17.69% | |
| NVO | NOVO NORDISK A S | $230.15B | $99.63 | N/A | N/A | Hold | 5 | 13.31% | 17.15% | 126.05% | 42.87% | |
| RPRX | ROYALTY PHARMA PLC | $24.40B | $40.18 | $52.00 | 29.42% | Strong Buy | 7 | 8.16% | 56.57% | 26.95% | 15.81% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.72B | $84.77 | $111.14 | 31.11% | Strong Buy | 8 | 19.05% | 130.24% | 19.31% | 14.15% | |
| UTHR | UNITED THERAPEUTICS CORP | $9.53B | $209.38 | $241.83 | 15.50% | Strong Buy | 7 | 9.16% | 11.72% | 24.44% | 19.04% | |
| INCY | INCYTE CORP | $14.82B | $66.64 | $84.13 | 26.24% | Hold | 9 | 11.21% | 8.67% | 42.09% | 32.33% | |
| TECH | BIO-TECHNE CORP | $11.14B | $284.00 | $476.00 | 67.61% | Buy | 5 | 14.55% | 16.87% | 25.16% | 18.66% | |
| CORT | CORCEPT THERAPEUTICS INC | $2.75B | $25.64 | $31.00 | 20.90% | Buy | 3 | 9.00% | 9.84% | 44.07% | 39.27% | |
| ABCM | ABCAM PLC | $3.43B | $14.99 | $20.00 | 33.42% | Hold | 1 | 14.69% | 54.96% | 16.77% | 11.46% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $74.26B | $289.54 | $294.67 | 1.77% | Buy | 12 | 5.84% | 3.97% | 30.84% | 23.62% | |
| VNDA | VANDA PHARMACEUTICALS INC | $558.83M | $9.88 | $12.00 | 21.46% | Hold | 1 | 1.38% | 4.79% | 3.34% | 2.79% |
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.